Literature DB >> 12170770

Paclitaxel-induced FasL-independent apoptosis and slow (non-apoptotic) cell death.

Mikhail V Blagosklonny1, Robert Robey, M Saeed Sheikh, Tito Fojo.   

Abstract

Microtubule-active drugs, including paclitaxel (Taxol, PTX), cause mitotic arrest, and this can result in apoptosis. A recently study has reported that PTX mediates apoptosis by upregulating FasL in Jurkat and MDA-231 cells. In contrast to the previous report, we found that anti-FasL antibodies failed to inhibit PTX-induced apoptosis in Jurkat cells. In MDA-231 cells, neither FasL nor PTX induced apoptosis. In these cells, PTX caused slow cell death without activation of caspase-3 or -8 or PARP cleavage. Doxorubicin at cytostatic concentrations did not affect FasL-induced apoptosis but inhibited PTX-induced apoptosis in Jurkat cells. Following PTX-induced mitotic arrest Jurkat cells undergo apoptosis, whereas MDA-MB-231 cells exit mitosis and form multinucleated cells which then die in a slower non-apoptotic manner.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12170770     DOI: 10.4161/cbt.53

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  10 in total

1.  The tubulysin analogue KEMTUB10 induces apoptosis in breast cancer cells via p53, Bim and Bcl-2.

Authors:  Oluwafunmilayo F Lamidi; Monica Sani; Paolo Lazzari; Matteo Zanda; Ian N Fleming
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-30       Impact factor: 4.553

2.  Moscatilin induces apoptosis and mitotic catastrophe in human esophageal cancer cells.

Authors:  Chien-An Chen; Chien-Chih Chen; Chien-Chang Shen; Hen-Hong Chang; Yu-Jen Chen
Journal:  J Med Food       Date:  2013-09-27       Impact factor: 2.786

3.  Protein kinase A type II-α regulatory subunit regulates the response of prostate cancer cells to taxane treatment.

Authors:  Evan R Zynda; Vitaliy Matveev; Michael Makhanov; Alexander Chenchik; Eugene S Kandel
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

4.  Wt p53 impairs response to chemotherapy: make lemonade to spare normal cells.

Authors:  Mikhail V Blagosklonny
Journal:  Oncotarget       Date:  2012-06

5.  Stochastic competition between mechanistically independent slippage and death pathways determines cell fate during mitotic arrest.

Authors:  Hsiao-Chun Huang; Timothy J Mitchison; Jue Shi
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

6.  NCI's provocative questions on cancer: some answers to ignite discussion.

Authors:  Mikhail V Blagosklonny
Journal:  Oncotarget       Date:  2011-12

7.  Dynamin-related protein Drp1 is required for Bax translocation to mitochondria in response to irradiation-induced apoptosis.

Authors:  Ping Wang; Peiguo Wang; Becky Liu; Jing Zhao; Qingsong Pang; Samir G Agrawal; Li Jia; Feng-Ting Liu
Journal:  Oncotarget       Date:  2015-09-08

8.  KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation.

Authors:  Paolo Lazzari; Marco Spiga; Monica Sani; Matteo Zanda; Ian N Fleming
Journal:  Hypoxia (Auckl)       Date:  2017-05-23

Review 9.  Rationale for combination of paclitaxel and CDK4/6 inhibitor in ovarian cancer therapy - non-mitotic mechanisms of paclitaxel.

Authors:  Elizabeth R Smith; Marilyn Huang; Matthew P Schlumbrecht; Sophia H L George; Xiang-Xi Xu
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

10.  Breaking malignant nuclei as a non-mitotic mechanism of taxol/paclitaxel.

Authors:  Elizabeth R Smith; Xiang-Xi Xu
Journal:  J Cancer Biol       Date:  2021
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.